Today we are delighted to congratulate Dr. Janet Rossant on the announcement of her winning the 2015 Canada Gairdner Wightman Award for outstanding leadership in medicine and medical science in Canada.
“Janet Rossant is not only an internationally acclaimed stem cell scientist, she has been a powerful force in moving the field forward and a leader in developing the roadmap for the future of our sector: the Canadian Stem Cell Strategy and Action Plan,” said James Price, President & CEO of the Canadian Stem Cell Foundation. “She has played a key role in ensuring that Canada stands among the top nations in the world in one of the most exciting and promising areas of medical research — stem cells.”
Dr. Rossant, who chairs the CSCF’s Science Leadership Council, was a member of the Foundation-led Joint Strategy Working Group that developed the Canadian Stem Cell Strategy & Action Plan. Based on a private/public partnership, it sets out how Canada can lead the way to deliver five to 10 new stem cell therapies to the clinic within 10 years.
“Her efforts have been invaluable,” said Mr. Price, who co-authored a Globe & Mail opinion piece with Dr. Rossant in February that illustrated how the Strategy could position Canada as an international centre for conducting safe, high-quality clinical trials for new stem cell treatments. “No one knows the field — and the remarkable things it can do — better than Janet. We are deeply proud of her accomplishments, and are thrilled for her success and the recognition she has received today.”
In a Foundation-produced video, Dr. Rossant declares that, “Research can’t stand still. Scientific research is always moving forward. We are at an incredibly exciting time in science when we can understand the underpinnings of disease and begin to translate that into new diagnoses and therapies.”
- The Canadian Stem Cell Strategy & Action Plan calls for a $1.5-billion public-private investment over 10 years, including a $50-million scaled annual average commitment by the Government of Canada.
- The Centre for Commercialization of Regenerative Medicine estimates the Canadian Stem Cell Strategy & Action Plan could generate more than 12,000 jobs for Canadians via the growth of existing companies and the development of new enterprises that reach global markets.
- In 2013, more than $200 billion was spent on health care in Canada. Two thirds of that money was used to treat incurable diseases. Stem cell research, cell therapy and regenerative medicine are working towards treatment options for these diseases.